The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (Nsaids)
Open Access
- 16 August 1999
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 190 (4) , 445-450
- https://doi.org/10.1084/jem.190.4.445
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradictionMedical Hypotheses, 2000
- Aberrant Crypt Foci of the Colon as Precursors of Adenoma and CancerNew England Journal of Medicine, 1998
- Sulindac sulfide inhibits Ras signalingOncogene, 1998
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Inhibition of the growth of 12V-ras-transformed rat fibroblasts by acetylsalicylic acid correlates with inhibition of NF-KBAnti-Cancer Drugs, 1997
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.Journal of Clinical Investigation, 1995
- Prostaglandin E2 Down-Regulates the Expression of HLA-DR Antigen in Human Colon Adenocarcinoma Cell LinesBiochemistry, 1995
- Regulation of Ras-GAP and the Neurofibromatosis-1 Gene Product by EicosanoidsScience, 1991